TYROBP and Alzheimer disease: Lee et al. identified conserved molecular signatures between AD mouse models and human brain tissue, including complement cascade activation, TYROBP-associated innate immune responses, and Tyro3/Axl/MerTK (TAM) receptor agonists, distinct from changes attributable to aging [254].